Welcome to LookChem.com Sign In|Join Free

CAS

  • or

175689-33-5

Post Buying Request

175689-33-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

175689-33-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 175689-33-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,6,8 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 175689-33:
(8*1)+(7*7)+(6*5)+(5*6)+(4*8)+(3*9)+(2*3)+(1*3)=185
185 % 10 = 5
So 175689-33-5 is a valid CAS Registry Number.

175689-33-5Relevant articles and documents

Benzonorbornadiene Derivatives and Reactions Thereof

-

, (2019/10/17)

A bioorthogonal molecule can include a molecule having a structure according the above wherein R1-R8 are independently selected from H, a substituted or unsubstituted C1-C4 alkyl or alkylene group, COOH, COORsu

Palladium-catalyzed regioselective allylation of five-membered heteroarenes with allyltributylstannane

Zhang, Sheng,Yu, Xiaoqiang,Feng, Xiujuan,Yamamoto, Yoshinori,Bao, Ming

, p. 3842 - 3845 (2015/03/30)

Palladium-catalyzed allylation reactions of 2-(chloromethyl)thiophenes, 2-(chloromethyl)furans, and N-protected 2-(chloromethyl)-1H-pyrroles with allyltributylstannane were described in this study. This type of allylation reaction regioselectively occurred on the heteroarene rings to produce allylated dearomatization products or allylated heteroarenes with satisfactory yields.

INHIBITORS OF DIPEPTIDYLPEPTIDASE IV

-

Page/Page column 69, (2008/06/13)

The present invention relates to inhibitors of post-proline cleaving enzymes, such as inhibitors of dipeptidyl peptidase IV, as well as pharmaceutical compositions thereof, and methods of using such inhibitors. In particular, the inhibitors of the present invention are improved over those in the prior art by selection of particular classes of sidechains in the P1 and/or P2 position of the inhibitor that contain a carboxylic acid moiety. The compounds of the present invention can have a better therapeutic index, owing in part to reduced toxicity and/or improved specificity for the targeted protease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 175689-33-5